A paranasal tumor associated with tumor-induced osteomalacia

Laryngoscope

Volumn 116, Issue 10, 2006, Pages 1930-1933

  Inokuchi, Go ^a   Tanimoto, Hitoshi ^a   Ishida, Haruhiko ^a   Sugimoto, Toshitsugu ^b   Yamauchi, Mika ^b   Miyauchi, Akimitsu ^c   Nibu, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^c National Hospital Organization Hyogo Chuo National Hospital   (Japan)

Author keywords

Fibroblast growth factor 23; Paranasal tumor; Tumor induced osteomalacia

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; PHOSPHATE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; FRACTURE; HUMAN; HUMAN TISSUE; LABORATORY TEST; NOSE OBSTRUCTION; OSTEOMALACIA; PARANASAL SINUS TUMOR; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; ALKALINE PHOSPHATASE; BONE DENSITY; FEMALE; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; MESENCHYMOMA; NASAL OBSTRUCTION; OSTEOMALACIA; PARANASAL SINUS NEOPLASMS; PARANEOPLASTIC SYNDROMES; PHOSPHATES; TUMOR MARKERS, BIOLOGICAL;

EID: 33749437323     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000231295.67060.89     Document Type: Article

References (9)

1. Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia- associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 2004;28:1-30.
2. Jonsson KB, Zahradnik R, Larsson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003;348:1656-1663.
3. Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001;98:6500-6505.
4. Walton RJ, Bijvoet OL. Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975;2:309-310.
5. Clunie GP, Fox PE, Stamp TC. Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management. Rheumatology 2000;39:1415-1421.
6. Linsey M, Smith W, Yamauchi H, Bernstein L. Nasopharyngeal angiofibroma presenting as adult osteomalacia: case report and review of the literature. Laryngoscope 1983;93:1328-1331.
7. Kobayashi K, Imanishi Y, Koshiyama H, et al. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci 2006;78:2295-2301.
8. Shimada T, Urakawa I, Yamazaki Y, et al. FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 2004;314:409-414.
9. Shimada T, Hasegawa H, Yamazaki Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004;19:429-435.